Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NUCB2 Kit ELISA

Le kit ELISA NUCB2 (ABIN415167) Humain est un kit ELISA Colorimetric conçu pour quantifier Humain NUCB2. Ce kit ELISA a été cité dans 19 publications.
N° du produit ABIN415167
770,00 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 11 à 15 jours ouvrables

Aperçu rapide pour NUCB2 Kit ELISA (ABIN415167)

Antigène

Voir toutes NUCB2 (NES1) Kits ELISA
NUCB2 (NES1) (Nesfatin-1 (NES1))

Reactivité

  • 13
  • 13
  • 10
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Humain

Méthode de détection

Colorimetric

Type de méthode

Competition ELISA

Gamme de detection

617.3 pg/mL - 50000 pg/mL

Application

ELISA

Type d'échantillon

Plasma, Serum
  • Seuil minimal de détection

    617.3 pg/mL

    Fonction

    The kit is a competitive inhibition enzyme immunoassay technique for the in vitro quantitative measurement of NES1 in Serum,Plasma,Biological Fluids

    Analytical Method

    Quantitative

    Specificité

    This assay has high sensitivity and excellent specificity for detection of Nesfatin 1 (NES1).
    No significant cross-reactivity or interference between Nesfatin 1 (NES1) and analogues was observed.

    Réactivité croisée (Details)

    No significant cross-reactivity or interference between Nesfatin 1 (NES1) and analogues was observed.

    Sensibilité

    < 234.2 pg/mL

    Ingrédients

    • Pre-coated, 96-well strip plate
    • Plate sealer
    • Standard
    • Standard Diluent
    • Detection Reagent A
    • Assay Diluent A
    • Detection Reagent B
    • Assay Diluent B
    • TMB Substrate
    • Stop Solution
    • Wash Buffer (30X)
    • Instruction manual

    Matériel non inclus

    • Microplate reader with 450 nm filter.
    • Precision single or multi-channel pipettes and disposable tips.
    • Eppendorf Tubes for diluting samples.
    • Deionized or distilled water.
    • Absorbent paper for blotting the microtiter plate.
    • Container for Wash Solution
  • Indications d'application

    • Limited by the current condition and scientific technology, we cannot completely conduct the comprehensive identification and analysis on the raw material provided by suppliers. So there might be some qualitative and technical risks to use the kit.
    • The final experimental results will be closely related to validity of the products, operation skills of the end users and the experimental environments. Please make sure that sufficient samples are available.
    • Kits from different batches may be a little different in detection range, sensitivity and color developing time.
    • Do not mix or substitute reagents from one kit lot to another. Use only the reagents supplied by manufacturer.
    • Protect all reagents from strong light during storage and incubation. All the bottle caps of reagents should be covered tightly to prevent the evaporation and contamination of microorganism.
    • There may be some foggy substance in the wells when the plate is opened at the first time. It will not have any effect on the final assay results. Do not remove microtiter plate from the storage bag until needed.
    • Wrong operations during the reagents preparation and loading, as well as incorrect parameter setting for the plate reader may lead to incorrect results. A microplate plate reader with a bandwidth of 10nm or less and an optical density range of 0-3 O.D. or greater at 450 ± 10nm wavelength is acceptable for use in absorbance measurement. Please read the instruction carefully and adjust the instrument prior to the experiment.
    • Even the same operator might get different results in two separate experiments. In order to get better reproducible results, the operation of every step in the assay should be controlled. Furthermore, a preliminary experiment before assay for each batch is recommended.
    • Each kit has been strictly passed Q.C test. However, results from end users might be inconsistent with our in-house data due to some unexpected transportation conditions or different lab equipments. Intra-assay variance among kits from different batches might arise from above factors, too.
    • Kits from different manufacturers for the same item might produce different results, since we have not compared our products with other manufacturers.

    Commentaires

    Information on standard material:
    The standard might be recombinant protein or natural protein, that will depend on the specific kit. Moreover, the expression system is E.coli or yeast or mammal cell. There is 0.05% proclin 300 in the standard as preservative.

    Information on reagents:
    The stop solution used in the kit is sulfuric acid with concentration of 1 mol/L. And the wash solution is TBS. The standard diluent contains 0.02 % sodium azide, assay diluent A and assay diluent B contain 0.01% sodium azide. Some kits can contain is BSA in them.

    Information on antibodies:
    The provided antibodies and their host vary in different kits.

    Volume d'échantillon

    50 μL

    Durée du test

    2 h

    Plaque

    Pre-coated

    Protocole

    1. Prepare all reagents, samples and standards;
    2. Add 50µL standard or sample to each well.
        And then add 50µL prepared Detection Reagent A immediately.
        Shake and mix. Incubate 1 hour at 37°C;
    3. Aspirate and wash 3 times;
    4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
    5. Aspirate and wash 5 times;
    6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
    7. Add 50µL Stop Solution. Read at 450 nm immediately.

    Précision du teste

    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Nesfatin 1 (NES1) were tested 20 times on one plate, respectively.
    Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Nesfatin 1 (NES1) were tested on 3 different plates, 8 replicates in each plate.
    CV(%) = SD/meanX100
    Intra-Assay: CV<10%
    Inter-Assay: CV<12%

    Restrictions

    For Research Use only
  • Précaution d'utilisation

    The Stop Solution suggested for use with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.

    Conseil sur la manipulation

    The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5 % within the expiration date under appropriate storage condition.
    To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

    Stock

    4 °C

    Stockage commentaire

    • For unopened kit: All the reagents should be kept according to the labels on vials. The Standard, Detection Reagent A, Detection Reagent B and the 96-well strip plate should be stored at -20°C upon receipt while the others should be at 4°C.
    • For opened kit: When the kit is opened, the remaining reagents still need to be stored according to the above storage condition. Besides, please return the unused wells to the foil pouch containing the desiccant pack, and reseal along entire edge of zip-seal.
      Note: It is highly recommended to use the remaining reagents within 1 month provided this is within the expiration date of the kit.
    • For ELISA kit, 1 day storage at 37°C can be considered as 2 months at 4°C, which means 3 days at 37°C equaling 6 months at 4°C.

    Date de péremption

    6 months
  • Xiao, Li, Jiang, Shao, Wang: "Plasma nesfatin-1 level is associated with severity of depression in Chinese depressive patients." dans: BMC psychiatry, Vol. 18, Issue 1, pp. 88, (2019) (PubMed).

    Ramesh, Gawli, Pasupulleti, Unniappan: "Metabolic and Cardiovascular Actions of Nesfatin-1: Implications in Health and Disease." dans: Current pharmaceutical design, Vol. 23, Issue 10, pp. 1453-1464, (2018) (PubMed).

    Ademoglu, Gorar, Keskin, Carlioglu, Ucler, Erdamar, Culha, Aral: "Serum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes." dans: Archives of endocrinology and metabolism, Vol. 61, Issue 5, pp. 455-459, (2018) (PubMed).

    Lu, Wang, Tang, Cheng, Du, Wang, Feng, Li, Cai, Qiu, Sun: "Nesfatin-1 functions as a switch for phenotype transformation and proliferation of VSMCs in hypertensive vascular remodeling." dans: Biochimica et biophysica acta. Molecular basis of disease, Vol. 1864, Issue 6 Pt A, pp. 2154-2168, (2018) (PubMed).

    Ustabaş Kahraman, Vehapoğlu, Özgen, Terzioğlu, Cesur, Dündaröz: "Correlation of Brain Neuropeptide (Nesfatin-1 and Orexin-A) Concentrations with Anthropometric and Biochemical Parameters in Malnourished Children." dans: Journal of clinical research in pediatric endocrinology, Vol. 7, Issue 3, pp. 197-202, (2016) (PubMed).

    Cakir, Calikoglu, Yılmaz, Akpinar, Bayraktutan, Topcu: "Serum nesfatin-1 levels: a potential new biomarker in patients with subarachnoid hemorrhage." dans: The International journal of neuroscience, pp. 1-7, (2016) (PubMed).

    Ahmadizad, Avansar, Ebrahim, Avandi, Ghasemikaram: "The effects of short-term high-intensity interval training vs. moderate-intensity continuous training on plasma levels of nesfatin-1 and inflammatory markers." dans: Hormone molecular biology and clinical investigation, Vol. 21, Issue 3, pp. 165-73, (2015) (PubMed).

    Ülger, Gül, Uslukaya, O?uz, Bozda?, Yüksel, Böyük: "New hormones to predict the severity of gallstone-induced acute pancreatitis." dans: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, Vol. 25, Issue 6, pp. 714-7, (2015) (PubMed).

    Alp, Görmüş, Güdücü, Bozkurt: "Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome." dans: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, Vol. 31, Issue 7, pp. 543-7, (2015) (PubMed).

    Araz, Yilmazel Ucar, Dorman, Bayraktutan, Yayla, Yilmaz, Acemoglu, Halici, Akgun: "Is There a Relationship between Obstructive Sleep Apnea Syndrome Severity and Nesfatin-1?" dans: Respiration; international review of thoracic diseases, Vol. 90, Issue 2, pp. 105-10, (2015) (PubMed).

    Sahin, Sahin, Ural, Cure, Senturk, Tekin, Balik, Cure, Yuce, Kirbas: "Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome." dans: Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences, Vol. 15, Issue 3, pp. 57-63, (2015) (PubMed).

    ?engül, Dilbaz, Hal?c?, Ferah, Çad?rc?, Y?lmaz: "Decreased serum nesfatin-1 levels in endometriosis." dans: European journal of obstetrics, gynecology, and reproductive biology, Vol. 177, pp. 34-7, (2014) (PubMed).

    Ademoglu, Gorar, Carl?oglu, Yaz?c?, Dellal, Berberoglu, Akdeniz, Uysal, Karakurt: "Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome." dans: Journal of endocrinological investigation, Vol. 37, Issue 8, pp. 715-9, (2014) (PubMed).

    Türko?lu, Böyük, Tanr?verdi, Gündüz, Dusak, Kaplan, Gümü?: "The potential role of BMI, plasma leptin, nesfatin-1 and ghrelin levels in the early detection of pancreatic necrosis and severe acute pancreatitis: a prospective cohort study." dans: International journal of surgery (London, England), Vol. 12, Issue 12, pp. 1310-3, (2014) (PubMed).

    Aslan, Celik, Celik, Turkcuoglu, Yilmaz, Karaer, Simsek, Celik, Aydin: "Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus." dans: Endocrine, Vol. 41, Issue 3, pp. 424-9, (2012) (PubMed).

    Gunay, Tutuncu, Aydin, Dag, Abasli: "Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder." dans: Psychoneuroendocrinology, Vol. 37, Issue 12, pp. 1949-53, (2012) (PubMed).

    Ari, Ozturk, Bez, Oktar, Erduran: "High plasma nesfatin-1 level in patients with major depressive disorder." dans: Progress in neuro-psychopharmacology & biological psychiatry, Vol. 35, Issue 2, pp. 497-500, (2011) (PubMed).

    Umut, Evren, Cansiz, Akkus, Karamustafalioglu: "Serum NUCB2/nesfatin-1 levels in different stages of alcohol dependence: Is there a relationship with craving?" dans: Indian journal of psychiatry, Vol. 59, Issue 1, pp. 94-99 (PubMed).

  • Antigène Voir toutes NUCB2 (NES1) Kits ELISA

    NUCB2 (NES1) (Nesfatin-1 (NES1))

    Autre désignation

    NES1

    UniProt

    P80303
Vous êtes ici:
Chat with us!